Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Original article

Vol. 155 No. 2 (2025)

Clinical outcomes and severe complications of hospitalised children and adolescents with varicella in central Switzerland: a retrospective observational study

DOI
https://doi.org/10.57187/s.3962
Cite this as:
Swiss Med Wkly. 2025;155:3962
Published
03.02.2025

Summary

AIM: Recent data on clinical complications and mortality among hospitalised children and adolescents due to varicella are unavailable in Switzerland. The aim of the study was to explore data on severe varicella complications in hospitalised children before the introduction of a universal varicella vaccination recommendation, which the Swiss Federal Office of Public Health implemented in January 2023.

METHODS: This was a retrospective observational study of children hospitalised with varicella between 01.01.2010 and 31.03.2020 at a tertiary children’s hospital in central Switzerland serving approximately 10% of the Swiss population. The inclusion criteria were acute varicella and/or related complications.

RESULTS: A total of 95 patients were identified. The median age at onset was 4 years (range: 2 months to 13 years) and the peak age of patients was between 1 and 4 years. 53 had mild and 42 patients had severe varicella-associated complications (8 had >1 severe complication). The most common severe complications were bacterial skin and soft tissue infections (n = 28), invasive secondary bacterial infections (n = 18), and central nervous system-related complications (n = 12). Admission to the paediatric intensive care unit and surgical intervention were required in 11 (12%) and 16 (17%) patients, respectively. Two previously healthy school-age children died because of secondary bacterial infections.

CONCLUSION: Our results demonstrate that varicella can cause severe and even fatal complications in children living in a highly developed country. This study provides valuable clinical data on severe varicella complications in hospitalised children from a large catchment area of Switzerland, facilitating future data comparison of the disease burden before and after the introduction of universal varicella vaccination in Switzerland.

References

  1. Piazza MF, Amicizia D, Paganino C, Marchini F, Astengo M, Grammatico F, et al. Has Clinical and Epidemiological Varicella Burden Changed over Time in Children? Overview on Hospitalizations, Comorbidities and Costs from 2010 to 2017 in Italy. Vaccines (Basel). 2021 Dec;9(12):1485. doi: https://doi.org/10.3390/vaccines9121485 DOI: https://doi.org/10.3390/vaccines9121485
  2. Wutzler P, Bonanni P, Burgess M, Gershon A, Sáfadi MA, Casabona G. Varicella vaccination - the global experience. Expert Rev Vaccines. 2017 Aug;16(8):833–43. doi: https://doi.org/10.1080/14760584.2017.1343669 DOI: https://doi.org/10.1080/14760584.2017.1343669
  3. Galil K, Brown C, Lin F, Seward J. Hospitalizations for varicella in the United States, 1988 to 1999. Pediatr Infect Dis J. 2002 Oct;21(10):931–5. doi: https://doi.org/10.1097/00006454-200210000-00009 DOI: https://doi.org/10.1097/00006454-200210000-00009
  4. Brisson M, Edmunds WJ, Law B, Gay NJ, Walld R, Brownell M, et al. Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiol Infect. 2001 Oct;127(2):305–14. doi: https://doi.org/10.1017/S0950268801005921 DOI: https://doi.org/10.1017/S0950268801005921
  5. Boëlle PY, Hanslik T. Varicella in non-immune persons: incidence, hospitalization and mortality rates. Epidemiol Infect. 2002 Dec;129(3):599–606. doi: https://doi.org/10.1017/S0950268802007720 DOI: https://doi.org/10.1017/S0950268802007720
  6. Ratner AJ. Varicella-related hospitalizations in the vaccine era. Pediatr Infect Dis J. 2002 Oct;21(10):927–31. doi: https://doi.org/10.1097/00006454-200210000-00008 DOI: https://doi.org/10.1097/00006454-200210000-00008
  7. Bundesamt für Gesundheit EKfIE. Windpocken (Varizellen)/ MMRV: Basisimpfung für Säuglinge. Bern: Bundesamt für Gesundheit; 2023.
  8. Lienert F, Weiss O, Schmitt K, Heininger U, Guggisberg P. Acceptance of universal varicella vaccination among Swiss pediatricians and general practitioners who treat pediatric patients. BMC Infect Dis. 2021 Jan;21(1):12. doi: https://doi.org/10.1186/s12879-020-05586-3 DOI: https://doi.org/10.1186/s12879-020-05586-3
  9. Bonhoeffer J, Baer G, Muehleisen B, Aebi C, Nadal D, Schaad UB, et al. Prospective surveillance of hospitalisations associated with varicella-zoster virus infections in children and adolescents. Eur J Pediatr. 2005 Jun;164(6):366–70. doi: https://doi.org/10.1007/s00431-005-1637-8 DOI: https://doi.org/10.1007/s00431-005-1637-8
  10. Seward JF, Watson BM, Peterson CL, Mascola L, Pelosi JW, Zhang JX, et al. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA. 2002 Feb;287(5):606–11. doi: https://doi.org/10.1001/jama.287.5.606 DOI: https://doi.org/10.1001/jama.287.5.606
  11. Siedler A, Hecht J, Rieck T, Tolksdorf K, Hengel H. [Varicella vaccination in Germany. A provisional appraisal in the context of MMR vaccination]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 Sep;56(9):1313–20. doi: https://doi.org/10.1007/s00103-013-1789-z DOI: https://doi.org/10.1007/s00103-013-1789-z
  12. Bundesamt für Gesundheit EKfI. Kantonales Durchimpfungsmonitoring Schweiz. BAG-Bulletin. 2018. Bull BAG. 2018;(24):13.
  13. Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. 2005;6(1). doi: https://doi.org/10.1097/01.PCC.0000149131.72248.E6 DOI: https://doi.org/10.1097/00130478-200501000-00033
  14. Lappin E, Ferguson AJ. Gram-positive toxic shock syndromes. Lancet Infect Dis. 2009 May;9(5):281–90. doi: https://doi.org/10.1016/S1473-3099(09)70066-0 DOI: https://doi.org/10.1016/S1473-3099(09)70066-0
  15. Eron LJ, Lipsky BA, Low DE, Nathwani D, Tice AD, Volturo GA. Managing skin and soft tissue infections: expert panel recommendations on key decision points. The Journal of antimicrobial chemotherapy. 2003;52 Suppl 1. doi: https://doi.org/10.1093/jac/dkg466 DOI: https://doi.org/10.1093/jac/dkg466
  16. A I, C A, K B, M B, AM S, U H. Prospective surveillance of varicella-zoster virus infections in an out-patient setting in Switzerland. Hum Vaccin. 2009;5(12). DOI: https://doi.org/10.4161/hv.9897
  17. Blumental S, Sabbe M, Lepage P; Belgian Group for Varicella. Varicella paediatric hospitalisations in Belgium: a 1-year national survey. Arch Dis Child. 2016 Jan;101(1):16–22. doi: https://doi.org/10.1136/archdischild-2015-308283 DOI: https://doi.org/10.1136/archdischild-2015-308283
  18. Turel O, Bakir M, Gonen I, Hatipoglu N, Aydogmus C, Hosaf E, et al. Children Hospitalized for Varicella: Complications and Cost Burden. Value Health Reg Issues. 2013;2(2):226–30. doi: https://doi.org/10.1016/j.vhri.2013.05.003 DOI: https://doi.org/10.1016/j.vhri.2013.05.003
  19. Chang LY, Huang LM, Chang IS, Tsai FY. Epidemiological characteristics of varicella from 2000 to 2008 and the impact of nationwide immunization in Taiwan. BMC Infect Dis. 2011 Dec;11(1):352. doi: https://doi.org/10.1186/1471-2334-11-352 DOI: https://doi.org/10.1186/1471-2334-11-352
  20. Bundesamt für Gesundheit EKfI. Schweizerischer Impfplan 2023. Richtlinien und Empfehlungen. Bern: Bundesamt für Gesundheit; 2023.
  21. Hagemann C, Krämer A, Grote V, Liese JG, Streng A. Specific Varicella-Related Complications and Their Decrease in Hospitalized Children after the Introduction of General Varicella Vaccination: Results from a Multicenter Pediatric Hospital Surveillance Study in Bavaria (Germany). Infect Dis Ther. 2019 Dec;8(4):597–611. doi: https://doi.org/10.1007/s40121-019-00273-6 DOI: https://doi.org/10.1007/s40121-019-00273-6
  22. Wen SC, Best E, Walls T, Dickson N, McCay H, Wilson E. Prospective surveillance of hospitalisations associated with varicella in New Zealand children. J Paediatr Child Health. 2015 Nov;51(11):1078–83. doi: https://doi.org/10.1111/jpc.12937 DOI: https://doi.org/10.1111/jpc.12937
  23. Abuhammour W, Hasan RA, Unuvar E. Group A beta-hemolytic streptococcal bacteremia. Indian J Pediatr. 2004 Oct;71(10):915–9. doi: https://doi.org/10.1007/BF02830836 DOI: https://doi.org/10.1007/BF02830836
  24. Laupland KB, Davies HD, Low DE, Schwartz B, Green K, McGeer A; Ontario Group A Streptococcal Study Group. Invasive group A streptococcal disease in children and association with varicella-zoster virus infection. Pediatrics. 2000 May;105(5):E60. doi: https://doi.org/10.1542/peds.105.5.e60 DOI: https://doi.org/10.1542/peds.105.5.e60
  25. Imöhl M, van der Linden M, Reinert RR, Ritter K. Invasive group A streptococcal disease and association with varicella in Germany, 1996-2009. FEMS Immunol Med Microbiol. 2011 Jun;62(1):101–9. doi: https://doi.org/10.1111/j.1574-695X.2011.00788.x DOI: https://doi.org/10.1111/j.1574-695X.2011.00788.x
  26. Coleman S. The association between varicella (chickenpox) and group A streptococcus infections in historical perspective. SAGE Open Med. 2016 Jul;4:2050312116658909. doi: https://doi.org/10.1177/2050312116658909 DOI: https://doi.org/10.1177/2050312116658909
  27. Savoia P, Heininger U, Buettcher M. Streptococcus pyogenes Endocarditis Associated With Varicella-Case Report and Review of the Literature. Front Pediatr. 2019 Dec;7:500. doi: https://doi.org/10.3389/fped.2019.00500 DOI: https://doi.org/10.3389/fped.2019.00500
  28. Kienast AK, Kreth HW, Höger PH. Varicella vaccination in children with atopic eczema. J Dtsch Dermatol Ges. 2007 Oct;5(10):875–80. doi: https://doi.org/10.1111/j.1610-0387.2007.06488.x DOI: https://doi.org/10.1111/j.1610-0387.2007.06488.x
  29. Han JH, Yoon JW, Yook HJ, Bang CH, Chun JH, Lee JY, et al. Evaluation of Atopic Dermatitis and Cutaneous Infectious Disorders Using Sequential Pattern Mining: A Nationwide Population-Based Cohort Study. J Clin Med. 2022 Jun;11(12):3422. doi: https://doi.org/10.3390/jcm11123422 DOI: https://doi.org/10.3390/jcm11123422
  30. Gerada C, Campbell TM, Kennedy JJ, McSharry BP, Steain M, Slobedman B, et al. Manipulation of the Innate Immune Response by Varicella Zoster Virus. Front Immunol. 2020 Jan;11:1. doi: https://doi.org/10.3389/fimmu.2020.00001 DOI: https://doi.org/10.3389/fimmu.2020.00001
  31. Tim MW, Jackson MA, Shannon K, Cohen B, McCracken GH Jr. Non-neonatal infection due to Listeria monocytogenes. Pediatr Infect Dis. 1984;3(3):213–7. doi: https://doi.org/10.1097/00006454-198405000-00006 DOI: https://doi.org/10.1097/00006454-198405000-00006
  32. Wright H, MacGregor A. A case of meningitis due to Bacterium monocytogenes. J Pathol Bacteriol. 1939;48(2):48. doi: https://doi.org/10.1002/path.1700480220 DOI: https://doi.org/10.1002/path.1700480220
  33. Science M, MacGregor D, Richardson SE, Mahant S, Tran D, Bitnun A. Central nervous system complications of varicella-zoster virus. J Pediatr. 2014 Oct;165(4):779–85. doi: https://doi.org/10.1016/j.jpeds.2014.06.014 DOI: https://doi.org/10.1016/j.jpeds.2014.06.014
  34. Ziebold C, von Kries R, Lang R, Weigl J, Schmitt HJ. Severe complications of varicella in previously healthy children in Germany: a 1-year survey. Pediatrics. 2001 Nov;108(5):E79. doi: https://doi.org/10.1542/peds.108.5.e79 DOI: https://doi.org/10.1542/peds.108.5.e79
  35. Bernal JL, Hobbelen P, Amirthalingam G. Burden of varicella complications in secondary care, England, 2004 to 2017. Euro Surveill. 2019 Oct;24(42):1900233. doi: https://doi.org/10.2807/1560-7917.ES.2019.24.42.1900233 DOI: https://doi.org/10.2807/1560-7917.ES.2019.24.42.1900233
  36. Gowin E, Wysocki J, Michalak M. Don’t forget how severe varicella can be—complications of varicella in children in a defined Polish population. Int J Infect Dis. 2013 Jul;17(7):e485–9. doi: https://doi.org/10.1016/j.ijid.2012.11.024 DOI: https://doi.org/10.1016/j.ijid.2012.11.024
  37. Guedes M, Filipe R, Costa A, Soares C, Sarmento A, Tavares M. Central nervous system varicella zoster vasculopathy in an immunocompromised patient. IDCases. 2018 Dec;15:e00483. doi: https://doi.org/10.1016/j.idcr.2018.e00483 DOI: https://doi.org/10.1016/j.idcr.2018.e00483
  38. Nagel MA, Niemeyer CS, Bubak AN. Central nervous system infections produced by varicella zoster virus. Curr Opin Infect Dis. 2020 Jun;33(3):273–8. doi: https://doi.org/10.1097/QCO.0000000000000647 DOI: https://doi.org/10.1097/QCO.0000000000000647
  39. Banz K, Iseli A, Aebi C, Brunner M, Schmutz AM, Heininger U. Economic evaluation of varicella vaccination in Swiss children and adolescents. Hum Vaccin. 2009 Dec;5(12):847–57. doi: https://doi.org/10.4161/hv.9898 DOI: https://doi.org/10.4161/hv.9898

Most read articles by the same author(s)

1 2 3 > >>